2008Humana Press eBooksRequires access

Ablative Preparative Regimens for Hematopoietic Stem Cell Transplantation

Amin M. Alousi, Marcos de Lima

Open publisher page 1 citations

Abstract

The combination of chemo-, radio- and biologic therapies in preparation for hematopoietic stem cell transplantation (HSCT) is referred to as conditioning (or preparative) regimen. As there is no one “standard” regimen, choosing the ideal regimen should take into account numerous factors including: stem cell source (autologous versus allogeneic), diagnosis, disease stage at the time of transplant, prior therapies, and comorbidities. There are few randomized studies comparing regimens and the majority of the data comes from phase 2 or retrospective analysis. Lacking clear-cut evidence supporting the superiority of one conditioning regimen over another, the choice is often based on institutional preference and experience. This chapter will review our current knowledge regarding ablative preparative regimens and some of the controversies that surround the field.

About this research paper

What this paper is about

The combination of chemo-, radio- and biologic therapies in preparation for hematopoietic stem cell transplantation (HSCT) is referred to as conditioning (or preparative) regimen. As there is no one “standard” regimen, choosing the ideal regimen should take into account numerous factors including: stem cell source (autologous versus allogeneic), diagnosis, disease stage at the time of transplant, prior therapies, and comorbidities. There are few randomized studies comparing regimens and the majority of the data comes from phase 2 or retrospective analysis. Lacking clear-cut evidence supporting the superiority of one conditioning regimen over another, the choice is often based on institutional preference and experience. This chapter will review our current knowledge regarding ablative preparative regimens and some of the controversies that surround the field.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The combination of chemo-, radio- and biologic therapies in preparation for hematopoietic stem cell transplantation (HSCT) is referred to as conditioning (or preparative) regimen. As there is no one “standard” regimen, choosing the ideal regimen should take into account numerous factors including: stem cell source (autologous versus allogeneic), diagnosis, disease stage at the time of transplant, prior therapies, and comorbidities. There are few randomized studies comparing regimens and the majority of the data comes from phase 2 or retrospective analysis. Lacking clear-cut evidence supporting the superiority of one conditioning regimen over another, the choice is often based on institutional preference and experience. This chapter will review our current knowledge regarding ablative preparative regimens and some of the controversies that surround the field.

Key concepts: Conditioning regimen, Regimen, Medicine, Hematopoietic stem cell transplantation, Transplantation, Stem cell, Oncology, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Ablative Preparative Regimens for Hematopoietic Stem Cell Transplantation — Research Paper | ScholarLens